Obsidian Therapeutics
-
2015
Company Description
Aspires to extend adoptive immunotherapy.
Obsidian Therapeutics, founded in 2015, aspires to extend adoptive immunotherapy to every patient with cancer. We do this by building cell therapies with pharmacologic operating systems to provide treating physicians with precise and dynamic control of engineered cells in patients.
-
Manufacturer:
Science and Engineering -
Formed:
2015 -
Company Website:
-
Company E-mail:
-
Company Address:
Obsidian Therapeutics, Inc.1030 Massachusetts AvenueSuite 400Cambridge, MAUnited States -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits